Clene Inc.
CLNN$56M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSALT LAKE CITY
Drugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Jun 15, 2026
13wMarket Overview
Stock performance and key metrics
CLNN News
Catalyst Timeline
2 upcoming, 1 past
Drug Pipeline
CNM-Au8
Relapsing Multiple Sclerosis
CNMAu8
Amyotrophic Lateral Sclerosis
CNM-ZnAg
Covid19
gold nanocrystals
Multiple Sclerosis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CNM-Au8 | Phase 3 | Relapsing Multiple Sclerosis | - | - |
CNMAu8 | Phase 2 | Amyotrophic Lateral Sclerosis | - | - |
CNM-ZnAg | Phase 2 | Covid19 | - | - |
gold nanocrystals | Phase 2 | Multiple Sclerosis | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply